Nitrome Biosciences is developing drugs against our newly discovered nitration enzyme(s). When successful, nitration enzymes will be amenable to drug development and we will have a novel inroad into a diversity of disease modifying drugs for neurodegenerative disease, heart disease and cancer. This would revolutionize standard of care for millions of people. Multi-billion dollar drug markets are predicted for these diseases, including PD.